Amgen, Inc. (AMGN)

NetscribeBiotech (73.62) Submitted: 2/12/07 7:46 AM : Start Price: $69.32 AMGN Score: -14.41

Amgen Inc. (Amgen) is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Amgen's principal products include Aranesp, Epogen, Neulasta, Neupogen and...

Report this Post Replies: 1 | Reply | Permalink

DemonDoug (99.98) Submitted: 12/18/07 1:41 PM : Start Price: $47.37 AMGN Score: 20.52

A bit risky maybe. Amgen is a solid company with a good portfolio of drugs and a history of good science and innovation. Appears to have bottomed, although I'm not a technical trader. I like Amgen as a company though, as I understand it the work e...

Report this Post Replies: 0 | Reply | Permalink

gstrout (< 20) Submitted: 6/17/06 7:59 PM : Start Price: $67.14 AMGN Score: -24.93

Proven ability to bring innovative therapies to market, solid financials, several strong revenue generating therapies in the market, a deep pipeline, heavy R&D spending, 3-4 mid-to-late stage products with good potential, and a price drop thanks to m...

Report this Post Replies: 0 | Reply | Permalink

kurto9 (< 20) Submitted: 12/26/06 7:20 PM : Start Price: $68.88 AMGN Score: 15.22

Underperformed it's peers this past year.

See Forbes 10/06 article on the problems facing Amgen in the near future.
- Expiring patents will hurt future profits
- JNJ is starting to compete in some areas
- Doctors are looking elsewhere due to Amgen'...

Report this Post Replies: 0 | Reply | Permalink

TMFZman (67.64) Submitted: 8/31/06 1:47 PM : Start Price: $68.63 AMGN Score: -22.44

As I pick it, this biotech behemoth sports multiples that reflect a steep discount to industry peers -- along with a healthy track record of growing cash flow and delivering the performance goods for shareholders.

Report this Post Replies: 1 | Reply | Permalink

not2eager (77.83) Submitted: 9/20/07 2:24 PM : Start Price: $55.30 AMGN Score: -9.16

Say goodbye to yesteryear. Management has engaged in almost every tactic to save the sinking ship: stock buybacks (which reenter the market as options), speculative takeovers to fill a weak pipeline, paying off doctors to over-prescribe lawyering t...

Report this Post Replies: 0 | Reply | Permalink

sleepyseth (98.78) Submitted: 11/03/06 3:05 PM : Start Price: $74.57 AMGN Score: -24.16

This is without a doubt the strongest biotech player. I beleive that they have been profitable longer than any other biotech ever and they offer as much of a saftey net as many of the well established pharmaceutical companies. The pipeline looks gr...

Report this Post Replies: 0 | Reply | Permalink

zirotti (84.36) Submitted: 1/23/07 1:40 AM : Start Price: $75.29 AMGN Score: -21.26

AMGN has an impressive lineup of blockbuster drugs and a good pipeline. Some recent acquistions are starting to pay off in terms of approved leading drugs. Financial health and industry leader should place AMGN into great long-term growth.

Report this Post Replies: 1 | Reply | Permalink

Jorgedig (45.74) Submitted: 12/01/07 12:25 PM : Start Price: $53.70 AMGN Score: -9.44

I sold my Amgen just before the new, strict Medicare guidelines came through on the use of Aranesp to treat chemotherapy-induced anemia.





I work in a cancer clinic, and we are very concerned that many of our patients are denie...

Report this Post Replies: 0 | Reply | Permalink

chevy88chase (< 20) Submitted: 12/14/06 1:36 PM : Start Price: $70.14 AMGN Score: -15.86

Amgen is a premier biotechnology company with excellent longer term growth prospects. However, it is currently being priced like a value stock with little or no growth prospects. Apparently the board of directors agrees that their stock is underval...

Report this Post Replies: 0 | Reply | Permalink